Skip to main content
. 2022 Jan 6;42(1):BSR20211783. doi: 10.1042/BSR20211783

Figure 6. The relationship of MTHFD1L expression with different clinicopathological features of LUAD.

Figure 6

(A) Expression of MTHFD1L in different cancer stages of LUAD patients, (B) expression of MTHFD1L in different races of LUAD patients, (C) expression of MTHFD1L in different genders of LUAD patients, and (D) expression of MTHFD1L in different age groups of LUAD patients. *P<0.05.